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doi:10.1016/j.ejvs.2011.04.033Abstract Introduction: Splanchnic and renal artery aneurysms (SRAAs) are uncommon but
potentially life-threatening in case of rupture. Whether these aneurysms are best treated by
open repair or endovascular intervention is unknown. The aim of this retrospective study is to
report the results of open and endovascular repairs in two European institutions over a fifteen-
year period. We have reviewed the available literature published over the 10 last years.
Methods: All patients with SRAAs diagnosed from 1995 to 2010 in St Marys Hospital (London, UK)
andHenri MondorHospital (Cre´teil, France)were reviewed. Preoperative clinical and anatomical
data, operative management and outcomes were recorded from the charts and analyzed.
Results: 40 patients with 51 SRAAs were identified. There were 21 males and 19 females with
a mean age of 57  14.9 years. The aneurysms locations were: 14 (27%) renal, 11 (22%) splenic,
7 (14%) celiac trunk, 7 (14%) superior mesenteric artery, 4 (8%) hepatic, 4 (8%) pancreaticoduo-
denal arcades, 3 (6%) left gastric and 1 (2%) gastroduodenal. 4 patients presentedwith a ruptured
SRAA. 17 SRAAs in 16 patients were treated by open repair, 15 in 15 patients were treated endo-
luminally and 17 (mean diameter: 18 mm, range: 8e75 mm) were managed conservatively. One
patient with metastatic pulmonary cancer with two mycotic aneurysms of the superior mesen-
teric artery (75 mm) and celiac trunk (15 mm) was palliated. After endovascular treatment,
the immediate technical success rate was 100%.
Therewas no significant difference between open repair and endovascular patients in terms of
30-day post-operative mortality rate and peri-operative complications. No in-hospital deathc.uk (R.G.J. Gibbs).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Contemporary Management of Splanchnic and Renal Artery Aneurysms 341occurred in patients treated electively. Postoperatively, four patients (1 ruptured and 3elective)
sufferednon-lethalmild to severe complication in theopen repair group, as comparedwithone in
the endovascular group (pZ .34). The mean length of stay was significantly higher after open
repair as compared with endovascular repair (17 days, range: 8e56 days vs. 4 days, range:
2e6; p < .001).
The mean follow-up time was 17.8 months (range: 0e143 months) after open repair, 15.8
months (range: 0e121 months) after endovascular treatment, and 24.8 (range: 3e64 months)
for patient being managed conservatively. No late death related to the VAA occurred. In each
group, 2 successful reoperations were deemed necessary. In the endovascular group, two
patients presented a reperfusion of the aneurysmal sac at 6 and 24 months respectively.
Conclusion: No significant difference in term of 30-day mortality and post-operative complica-
tion rates could be identified between open repair and endovascular treatment in the present
series. Endovascular treatment is a safe alternative to open repair but patients are exposed to
the risk of aneurysmal reperfusion. Thismandates careful long-term imaging followup in patients
treated endoluminally.
ª 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Splanchnic and renal artery aneurysms (SRAAs) are rare but
increasingly diagnosed entities with current use of abdom-
inal ultrasonography and computer tomographic (CT)
imaging modalities.1 The most commonly involved arteries
are renal, splenic, and hepatic arteries.1e5 They represent
a serious and potentially lethal condition when rupture
occurs. This paper, describes a combined series from two
major European vascular departments, presents the
outcomes of surgical and minimally invasive intervention,
and examines the impact of endovascular techniques on the
management of this condition.We also report an overview of
the literature on SRAAs published during the last ten years.Methods
A retrospective review of all patients with the diagnosis of
SRAA at St Marys Hospital (London, UK) and Henri Mondor
hospital (Cre´teil, France) from January 1995 to May 2010
was undertaken. Anastomotic pseudoaneurysms and aortic
aneurysms involving the visceral arteries were excluded
from this series. The records for all patients were analyzed
with regards to demographic and clinical data, imaging
studies, intraoperative data, and early and late outcomes.
The decision to perform an open repair, an endovascular
intervention or conservative management was made after
discussion in a multidisciplinary meeting. All ruptured and
infected SRAAs underwent intervention. Infected aneu-
rysms were defined by the presence of sepsis (fever,
leukocytosis, and pain), positive cultures (blood/tissue) or
characteristic radiological findings (irregular aortic wall,
rapid growth rate and saccular or lobulated aneurysm).
Negative blood cultures and absence of pyrexia were not
used as exclusion criteria.
Open repair consisted of aneurysmorrhaphy with or
without vascular reconstruction by means of direct end-to-
end anastomosis using vein or prosthetic graft interposition.
When hilar splenic aneurysms were treated surgically, aneu-
rysm resection and splenectomy was performed. Endovas-
cular treatmentconsistedeitherofcoil embolization, coveredstent placement or combined procedures utilizing stenting/
and or coil embolization and/or Onyx injection (ev3, Irvine,
CA, USA). Decisions regarding the use of stents coils or Onyx
material were made intra-operatively on a patient-specific
basis, depending on the anatomical characteristics of the
aneurysm and specific angiographic findings. Covered stents
were used in caseswith adequate sealing zones,whereas coils
were preferred in the presence of collaterals. Onyx material
was used in cases of persistent sac perfusion or for voluminous
aneurysms. Immediate technical success of endovascular
repair was defined as the absence of flow in the VRAA on
completion angiography.
Following open surgical correction, patients underwent
duplex scanning prior to discharge, at 3, 6 months and yearly
thereafter. CT scanning was performed if ultrasonography
was inconclusive or an abnormality was seen such as aneu-
rysm reperfusion or anastomotic stenosis/occlusion.
Following endovascular repair, follow-up consisted of CT
imaging 1e3months post-procedure andCT/duplex scanning
every one to two years thereafter. Patients treated conser-
vatively underwent CT scanning every 6e24 months. For the
purpose of this study, clinical and anatomical data, early and
mid-termoutcomeswere comparedbetween theopen repair
group and endovascular group. Patients were considered as
lost to follow-up if they lacked at least one follow-up imaging
study, or failed to appear in a follow-up clinic.
Statistical analysis
Proportions and categorical variables were compared using
a Fisher’s exact test. Continuous data were compared using
a ManneWhitney. All tests were two-sided. P < .05 was
considered as statistically significant.
Literature search
Series of renal and visceral artery aneurysms published in
English between 2000 and 2010 were identified on Medline.
Mesh headings included: “visceral artery aneurysm”,
“splanchnic artery aneurysm”, and “renal artery aneu-
rysm”. References cited in publications identified by Med-
line research were examined in order to identify any
Figure 1 Proportions of patients treated by open repair and
endovascular repair by date of operation.
342 F. Cochennec et al.missing study. Splanchnic artery aneurysms were defined as
those involving the celiac trunk (splenic and hepatic
arteries, pancreaticoduodenal arcade, gastroduodenal
artery, and left gastric artery), superior and inferior
mesenteric arteries and branches. Publications on anasto-
motic pseudoaneurysms after hepatic transplantation were
excluded. Only more than 10 patients series were included.
Results
Forty patients with 51 SRAAs were identified (St Marys
Hospital: 22 patients, 32 SRAAs; Henri Mondor Hospital: 18
patients, 19 VRAAs; see Fig. 1), 21 men and 19 women with
a mean age of 57  14.9 years. In all, there were 14 (27%)
renal artery aneurysms, 11 (22%) splenic artery aneurysms,
7 (14%) celiac trunk aneurysms, 7 (14%) aneurysms of the
superior mesenteric artery, 4 (8%) hepatic artery aneu-
rysms, 4 (8%) aneurysms of the pancreaticoduodenal
arcades, 3 (5%) left gastric artery aneurysms and 1 (2%)
gastroduodenal artery aneurysm. The mean diameter was
21  13 mm (range: 8e75). Four patients presented with
a ruptured SRAA, of which two were infected. Three other
non-ruptured SRAAs in two patients were considered to be
infected predicated on characteristic CT appearance on CTTable 1 Associated comorbidities of patients with visceral arte
St Marys (n Z 22)
Males, n (%) 16 (73)
Mean age (SD) 57  15
Hypertension, n (%) 10 (45)
Diabetes mellitus, n (%) 1 (5)
Hypercholesterolemia, n (%) 5 (23)
Smoking, n (%) 2 (9)
Coronary artery disease, n (%) 1 (5)
Heart failure, n (%) 3 (14)
COPD, n (%) 0
Connective tissue disorder 1 polychondritis
1 polyaneurysmal dystroand clinical presentation. Five patients presented with
a non-ruptured but tender SRAA. The clinical and demo-
graphic data are summarized in Table 1. Hypertension was
the most common cardiovascular risk factor (47.5%).
Intervention was undertaken for 32 SRAAs with a mean
diameter of 23 10 mm (range: 11e50 mm). Of those, 17
SRAAs in 16 patients were treated by open repair and 15
SRAAs in 15 patients were managed endoluminally. The
proportions of open and endovascular repairs according to
the date of intervention are shown in Fig. 2: 0%, 37% and
52% of patients were treated endoluminally in 1995e2000,
2000e2005, and 2005e2010 respectively. Following endo-
vascular treatment, the immediate technical success rate
was 100%. The main clinical and anatomical data in relation
to the type of treatment are summarized in Tables 2 and 3.
Procedure details are given in Table 3.
Seventeen SRAAs in 13 patients with a diameter <20 mm
were managed conservatively. One patient with metastatic
pulmonary cancer with two infected aneurysms of the
superior mesenteric artery (75 mm) and celiac trunk
(15 mm), was managed conservatively due to short life
expectancy; he succumbed two months later of his
pulmonary disease.
There was no significant difference between the open
repair and endovascular groups with respect to 30-day post-
operative mortality and peri-operative complications. No in-
hospital death occurred in patients treated electively. One
female patient died after emergent endovascular repair of
a ruptured infected splenic aneurysm, who had undergone
aortic valve replacement one week prior for a severe endo-
carditis and an aortic root abscess. Despite a successful
endovascular aneurysm exclusion with coil embolization and
Onyx placement, she subsequently died of septic shock.
Postoperatively, four patients (1 ruptured and 3 elec-
tive) suffered complications in the open repair group,
compared with one in the endovascular group (pZ .34). In
the open repair group, one patient with a ruptured infected
aneurysm of the superior mesenteric artery treated by
resection and saphenous vein interposition, developed
pneumonia requiring prolonged intubation. One patient
(non-rupture) subsequently developed a subcapsular
hepatic hematoma treated with endovascular embolization
and went on to develop pneumonia. Two cases of elective
splenic artery ligation and splenectomy were complicatedry aneurysms in St Marys Hospital and Henri Mondor Hospital.
Henri Mondor (n Z 18) p
5 (28) 0.01
56  15 0.95
9 (50) 1
2 (11) 0.59
3 (17) 0.71
2 (11) 1
1 (6) 1
2 (11) 1
0 1
phy
1 Recklinghausen disease
1 EhlerseDanlos disease type IV
1 Behcet disease
Figure 2 Treatment by open repair and endovascular repair
by date of operation.
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managed conservatively.
In the endovascular group, one patient presented with
severe post-embolization syndrome with splenic infarcts
following splenic artery embolization and was re-admitted
for pain control. The mean length of stay was significantly
higher after open repair as compared with endovascular
repair (17 days, range: 8e56 days vs. 4 days, range: 2e6;
p < .001).
The mean follow-up was 15.6 months (range: 0e143),
17.8 months (0e143) after open repair and 15.8 months
(0e12) after endovascular treatment. Six patients were lost
to follow-up. No death related to the SRAA occurred.
In each group, 2 reoperations were necessary. In the
open repair group, one patient with a celiac trunk aneu-
rysm treated with resection and thoracic aortic to
common hepatic saphenous vein bypass was successfully re-
operated on day 1 to shorten the vein bypass whichTable 2 Clinical and demographic data by treatment modality.
Open Repair Group (n Z 16 p
Males, n (%) 7 (44)
Mean diameter (mm  SD) 26  12
Mean age (SD) 55  14
Hypertension, n (%) 9 (56)
Diabetes mellitus, n (%) 1 (6)
Hypercholesterolemia, n (%) 2 (12)
Smoking, n (%) 0
Coronary artery disease, n (%) 0
Heart failure, n (%) 0
COPD, n (%) 0
Symptomatic aneurysm 6 (37)
Painful 3 (19)
Mycotic 2a (12)
Gastrointestinal bleeding 0
Hemobilia 0
Ruptured 2 (12)
a Two patients had a mycotic ruptured VAA (one treated by open, on
of the superior mesenteric artery and celiac trunk, and a metastatic
antibiotics.appeared kinked on post-operative CT scan. The second
patient presenting with a non-ruptured hepatic artery
aneurysm was re-operated on day 1 for a tight stenosis of
the proximal anastomosis of an aorto-hepatic prosthetic
bypass. In the endovascular group two patients presenting
with a renal artery and a splenic artery aneurysm required
further intervention for reperfusion of the aneurysmal sac
at 6 months and 2 years respectively. The patient with the
renal artery aneurysm underwent an uncomplicated open
ligation of the ipsilateral renal artery, without revascular-
ization or nephrectomy due to poor renal perfusion on pre-
operative imaging, and the patient with the splenic artery
aneurysm had a successful iterative endovascular treat-
ment using an uncovered stent, coils and Onyx (see Fig. 3).
The mean follow-up time was 24.8 (range: 3e64 months)
for patients managed conservatively. No patient ruptured
during the follow-up period.Discussion
The present study showed no significant difference
between open and endovascular repair of SRAAs in terms of
early post-operative mortality, complication and re-
operation rates. The question of whether SRAAs should be
treated by open or endovascular repair has never been
addressed by a controlled randomized study, and only few
retrospective series have been published.5,6 Their findings
were consistent with the results reported in the present
series.
In order to better evaluate the results of open repair and
endovascular repair of SRAAs, we reviewed the literature. In
all, we identified 1299 patients with 1528 aneurysms from 29
different publications2e29 from the last ten years, including
the present study. Among those series, eight included
patients with pseudoaneurysms. There were 147 (11%)
patients with ruptured aneurysms and 217 (17%) patients
with symptomatic non-ruptured SRAAs. The commonest sitesatients) Endovascular group (n Z 15 patients) p
5 (30) 0.72
207 0.40
60  10 0.36
5 (30) 0.29
2 (13) 0.60
4 (27) 0.39
1 (7) 0.48
1 (7) 0.48
2 (13) 0.23
0 1
4 (27) 0.70
2 (13) 1
1a (7) 1
0 1
0 1
2 (13) 1
e endovascular repair). One patient with two mycotic aneurysms
pulmonary cancer was managed conservatively with intravenous
Table 3 Aneurysm location and management.
Open repair (17 aneurysms) Endovascular repair
(15 aneurysms)
Splenic artery (n Z 9) -Splenectomy: 2
-Aneurysmorrhaphy þ end to end anastomosis: 3
-Coils: 3a
-Coils þ Onyx: 1a
Renal arteries (n Z 7) -Aneurysmorrhaphy þ ligation: 2 -Covered stent: 2
-Coils:1
-Coils þ Onyx: 1
-Covered stent þ coils: 1
Celiac trunk (n Z 5) -Aneurysmorrhaphy þ aorto-hepatic prosthetic bypass: 2 -Covered stent: 2
-Covered stent þ coils
þ Onyx: 1
Pancreaticoduodenal arcades (n Z 4) -Aneurysmorrhaphy: 4 0
Left gastric artery (n Z 3) 0 -Coils: 3
Hepatic artery (n Z 2) -Aneurysmorrhaphy þ Aorto-hepatic prosthetic bypass: 1
-Aneurysmorrhaphy þ Aorto-hepatic venous bypass: 1a
0
Superior mesenteric artery (n Z 2) -Aneurysmorrhaphy þ Aorto-mesenteric venous bypass: 2a 0
a Includes one ruptured aneurysm.
Figure 3 Late reperfusion of a splenic aneurysm 2 years
after a coil embolization. Successful treatment by non-covered
stenting and redo coil embolization with injection of onyx
through the meshes of the stent.
344 F. Cochennec et al.were the renal (35%), splenic (11%), hepatic (6%) and superior
mesenteric (5%) arteries.2e5 The mean age varied from 46 to
66 years. Aetiologies included atherosclerosis (51.3%), post-
traumatic (12%), fibromuscular dysplasia (11%), infective
(7%), post-pancreatitis (7%) and inflammatory arteritis (4%).
for splanchnic aneurysms whereas fibromuscular dysplasia
(68%), atherosclerosis (24%), and dissections (3%) for renal
artery aneurysms.
Surgical treatment of SRAAs is clearly indicated in cases
of rupture, symptoms and infective pathogenesis.1
However, indications for surgical repair of asymptomatic
lesions remain controversial. Due to a high risk of rupture
during pregnancy with high mortality rates,16,30,31 renal and
splenic aneurysms in women of childbearing age should be
treated. SRAAs associated with arteritis like polyarteritis
nodosa and fibromuscular dysplasia have been linked with
increased rupture rates and reports have suggested they
should also be treated aggressively.1 The relationship
between renal artery aneurysms and hypertension has
been emphasized and some authors believe that poorly
controlled hypertension should be an indication for surgical
repair.13,32
Currently, no consensus exists for the size at which
SRAAs should be repaired in asymptomatic patients, even
though those with a diameter less than 20 mm are consid-
ered to be at low risk for rupture. The natural history of
SRAAs has been best illustrated by the Mayo Clinic experi-
ence:7,8 168 splenic (70% < 20 mm), and 22 hepatic artery
aneurysms (82% < 20 mm) were managed conservatively
during a mean follow-up of 74 and 68 months respectively.
None of these aneurysms ruptured. We identified nine
studies describing the outcome of 356 patients managed
conservatively. With a mean period varying from 15 to 75
months, only one (0.3%) rupture occurred.
Analysis of the literature showed that 678 patients
underwent open repair, 278 an endovascular repair and 309
were treated conservatively. The overall success rate of
endovascular treatment, defined as the exclusion of the
aneurysmal sac on the completion angiography, was 89.7%
(262/292). Table 4 summarizes the post-operative mortality
Table 4 Postoperative mortality rates by presentation, treatment type, and location of the aneurysm.
Open repair Endovascular Repair Total
Ruptured cases 17/71, (23.9) 1/37, (2.7) 22/142, (15.5)
Spanchnic artery 16/67, (23.9) 1/37, (2.7) 21/138 (15.2)
Renal artery 1/4, (25) 0/0 1/4, (25)
Elective cases 7/561, (1.2) 2/163, (1.2) 9/800, (1.1)
Splanchnic artery 6/252, (2.4) 0/163, (0) 8/491, (1.6)
Renal artery 1/309, (0.3) 0/0 1/309, (0.3)
Total 20/666, (3.0) 10/276 (3.6)
Splanchnic artery 18/353, (7.1) 10/276 (3.6)
Renal artery 2/313, (0.6) 0/0
Each sub group is described as follows: number of deaths/number of patients with data available, (%).
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treatment modality, and aneurysm location. Although no
reliable statistical analysis can be performed from these
retrospective studies, certain findings should taken into
consideration. The 15.5% mortality rate seen in patients
treated for ruptured SRAAs is not as high as the traditional
20e70% described in the last two decades of the twentieth
century.16,33e36 This might be explained by the increasing
use of endovascular techniques and improvements in peri-
operative management. This review suggests that the
benefits of endovascular therapy in terms of post-operative
mortality is more evident for ruptured cases (2.7% endo-
vascular vs. 23.9% open) and not as high as expected for
patients treated electively, for whom the post-operative
mortality rates were low (1.2% in each group).
No study has clearly demonstrated that endovascular
treatment of SRAAs is associated with a reduction of post-
operative complications when compared with open repair.
Specific to the endovascular treatment of splenic and
hepatic aneurysms is the development of a “post - embo-
lization syndrome”, characterized by a combination of
fever, abdominal pain due to splenic or hepatic infarcts,
and pancreatitis seen in up to 30% of cases.17 In our series,
it occurred in one patient treated for a splenic aneurysm.
Abscess formation secondary to end-organ infarct has also
been reported.5,6
Further intervention was required for 4 patients in our
series. The literature reports that further treatment was
deemed necessary in 6.9% of patients treated by open
repair versus 11.1% of patients treated endoluminally. In
the series in which the mid-term or long-term patency rates
after open procedures were reported, 89.2%e100% of
vascular reconstructions remained patent after a mean
follow-up of 17.8e91 months.4,6,8,9,13,16,18,20,23 In the
endovascular group, of the 241 patients assessed for SRAA
reperfusion during a mean follow-up of 10e78 months,
aneurysm sac reperfusion was seen in nineteen patients
(7.9%). In our series, two patients presented with reperfu-
sion at 2 years and 6 months respectively. This suggests that
close imaging surveillance is necessary for patients treated
by endovascular means. Long-term surveillance in a rela-
tively younger cohort than the traditional atherosclerotic
degenerative group undergoing stentgraft placement also
raises questions as to both durability and repeatedradiation exposure. Younger patients therefore, treated
electively, may be better served with open repair where
the mortality between the two modalities is very similar,
whilst endovascular repair should be considered as a first-
line treatment for older patients electively and all
patients presenting with rupture.Conclusion
SRAAs are rare but a serious condition. Conservative
management with careful surveillance can be undertaken
in those aneurysms with a diameter of less than 20 mm with
the exception of women of childbearing age in whom
rupture risk is high. Endovascular treatment is a valid
alternative to open repair, especially for ruptured cases.Conflict of Interest/Funding
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